Orion ja Invenra sol
Orion ja Invenra solmivat tutkimuspalvelu- ja kaupallisen lisenssisopimuksen syöpähoitoihin tarkoitettujen innovatiivisten bispesifisten vasta-aineiden kehittämiseksi
January 30, 2025 09:00 ET | Orion Oyj
ORION OYJ                LEHDISTÖTIEDOTE 30.1.2025 KLO 16.00          Orion ja Invenra solmivat tutkimuspalvelu- ja kaupallisen lisenssisopimuksen syöpähoitoihin tarkoitettujen innovatiivisten...
Orion and Invenra an
Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics
January 30, 2025 09:00 ET | Orion Oyj
ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET                   Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific...
22157.jpg
Asia-Pacific Compression Therapy Market Outlook to 2033, Featuring Key Players Cardinal Health, BSN Medical, Paul Hartmann, 3M Co., Lohmann & Rauscher GmbH & Co, Sigvaris, Thuasne, and Smith & Nephew
January 30, 2025 08:00 ET | Research and Markets
Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Compression Therapy Market Outlook to 2033 - Pneumatic Compression Therapy and Static Compression Therapy" report has been added to ...
Sanofi new_logo.jpg
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Decembre 2024
January 29, 2025 17:13 ET | Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi new_logo.jpg
Sanofi: Information concerning the total number of voting rights and shares - December 2024
January 29, 2025 17:13 ET | Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
MicrosoftTeams-image (1).png
Virtual Science AI Unveils Real-Time Intelligent Q&A Feature for Life Science Insights
January 29, 2025 08:20 ET | Virtual Science
Virtual Science AI Unveils Real-Time Intelligent Q&A Feature for Life Science Insights
Phathom_Pharm_Logo.jpg
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference
January 29, 2025 08:00 ET | Phathom Pharmaceuticals
FLORHAM PARK, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
cmi_logo.png
[Latest] Global Cocoa and Chocolate Market Size/Share Worth USD 10.86 Billion by 2033 at a 6.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
January 28, 2025 13:00 ET | Custom Market Insights
Austin, TX, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cocoa and Chocolate Market Size, Trends and Insights By Product Type (Butter,...
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
January 28, 2025 05:30 ET | Conduit Pharmaceuticals
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
AnavexLogoR-Transparent @3x.png
Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
January 27, 2025 07:30 ET | Anavex Life Sciences Corp.
Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent for Alzheimer's Disease